Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
91.22 USD | -1.35% | -1.25% | -13.65% |
12:46pm | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Sales 2024 * | 2.8B 3.04B | Sales 2025 * | 2.77B 3.01B | Capitalization | 20.55B 22.33B |
---|---|---|---|---|---|
Net income 2024 * | -415M -451M | Net income 2025 * | -491M -534M | EV / Sales 2024 * | 2.06 x |
Net cash position 2024 * | 14.78B 16.06B | Net cash position 2025 * | 13.76B 14.96B | EV / Sales 2025 * | 2.45 x |
P/E ratio 2024 * |
-49
x | P/E ratio 2025 * |
-43.5
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | +2.05% | ||
1 week | -0.27% | ||
Current month | +4.11% | ||
1 month | +6.52% | ||
3 months | +1.35% | ||
6 months | -6.44% | ||
Current year | -12.38% |
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 08-06-01 |
Özlem Türeci
FOU | Founder | 57 | 08-06-01 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 69 | 21-12-31 |
Director/Board Member | 67 | 08-06-01 | |
Helmut Jeggle
CHM | Chairman | 53 | 08-06-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.92% | 1 M€ | +0.15% | - | |
2.63% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 91.13 | -1.45% | 122 777 |
24-05-20 | 92.47 | +2.05% | 340,966 |
24-05-17 | 90.61 | -2.55% | 471,775 |
24-05-16 | 92.98 | +0.85% | 389,150 |
24-05-15 | 92.2 | -0.09% | 468,427 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.38% | 22.31B | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.52% | 21.6B | |
-6.91% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- BNTX Stock